T. Smith

发表

Inactivated Rabies Virus-Vectored Immunocontraceptive Vaccine in a Thermo-Responsive Hydrogel Induces High and Persistent Antibodies against Rabies, but Insufficient Antibodies against Gonadotropin-Releasing Hormone for Contraception

Todd G. Smith, L. Seigler, V. Olson, 2019, Vaccines.

Revisiting rabies virus neutralizing antibodies through infecting BALB/c mice with live rabies virus.

Todd G. Smith, Clint N. Morgan, F. Jackson, 2018, Virus research.

Design of future rabies biologics and antiviral drugs.

Todd G. Smith, C. Rupprecht, R. Franka, 2011, Advances in virus research.

Antiviral Ranpirnase TMR-001 Inhibits Rabies Virus Release and Cell-to-Cell Infection In Vitro

Todd G. Smith, T. Hodge, L. Greenberg, 2020, Viruses.

Current and future tools for global canine rabies elimination.

Todd G. Smith, C. Rupprecht, M. Niezgoda, 2013, Antiviral research.

Lyssavirus Vaccine with a Chimeric Glycoprotein Protects across Phylogroups

Todd G. Smith, G. Cingolani, C. Wirblich, 2020, Cell Reports.

Comparison of a Micro-Neutralization Test with the Rapid Fluorescent Focus Inhibition Test for Measuring Rabies Virus Neutralizing Antibodies

Todd G. Smith, A. Gilbert, T. Smith, 2017, Tropical medicine and infectious disease.

An electrochemiluminescence assay for analysis of rabies virus glycoprotein content in rabies vaccines.

Todd G. Smith, C. Rupprecht, N. Kuzmina, 2013, Vaccine.

Evaluation of immune responses in dogs to oral rabies vaccine under field conditions.

Todd G. Smith, J. Blanton, R. Chipman, 2017, Vaccine.

From brain passage to cell adaptation: the road of human rabies vaccine development

Todd G. Smith, C. Rupprecht, Xianfu Wu, 2011, Expert review of vaccines.

Multiple lineages of Monkeypox virus detected in the United States, 2021- 2022

Todd G. Smith, Bette Korber, J. Theiler, 2022, bioRxiv.

Identification of Tecovirimat Resistance-Associated Mutations in Human Monkeypox Virus - Los Angeles County

N. K. Shah, P. Hemarajata, N. Green, 2023, Antimicrobial agents and chemotherapy.

Serological responses to the MVA-based JYNNEOS monkeypox vaccine in a cohort of participants from the Democratic Republic of Congo

Todd G. Smith, B. Monroe, E. Okitolonda, 2022, Vaccine.

Evidence of mpox virus infection among persons without characteristic lesions or rash presenting for first dose of JYNNEOS vaccine-District of Columbia, August 2022.

P. Dawson, M. Waltenburg, P. Weidle, 2023, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

A cocktail of human monoclonal antibodies broadly neutralizes North American rabies virus variants as a promising candidate for rabies post-exposure prophylaxis

Todd G. Smith, M. Klempner, Yang Wang, 2022, Scientific Reports.

Bat and Lyssavirus Exposure among Humans in Area that Celebrates Bat Festival, Nigeria, 2010 and 2013

Todd G. Smith, N. M. Vora, C. Rupprecht, 2020, Emerging infectious diseases.

Assessment of the immunogenicity of rabies vaccine preserved by vaporization and delivered to the duodenal mucosa of gray foxes (Urocyon cinereoargenteus).

Todd G. Smith, C. Hanlon, R. Franka, 2017, American journal of veterinary research.

Rabies vaccine preserved by vaporization is thermostable and immunogenic.

Todd G. Smith, M. Siirin, C. Hanlon, 2015, Vaccine.

Human Rabies - Missouri, 2014.

Todd G. Smith, R. Franka, A. Wadhwa, 2016, MMWR. Morbidity and mortality weekly report.

Resistance to anti-orthopoxviral drug tecovirimat (TPOXX(R)) during the 2022 mpox outbreak in the US

Y. Yang, B. Petersen, P. S. Satheshkumar, 2023, medRxiv.

Inactivated Rabies Virus-Based Ebola Vaccine Preserved by Vaporization Is Heat-Stable and Immunogenic Against Ebola and Protects Against Rabies Challenge.

Todd G. Smith, R. Franka, M. Schnell, 2019, The Journal of infectious diseases.